INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING PROSTATE CANCER WITH BISPECIFIC ANTI-PSMA X ANTI-CD3 ANTIBODIES AND BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES"

GENEVA, Aug. 19 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/014779) for "METHODS OF TREATING PROSTATE CANCER WITH BISPECIFIC ANTI-PSMA X ANTI-CD3 ANTIBODIES AND BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES" on Feb 06, 2025. With publication no. WO/2025/171124, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): INGHAM, Matthew (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), MILLER, Elizabeth (c/o Rege...